background
impact
viral
infect
acut
exacerb
idiopath
pulmonari
fibrosi
ipf
andor
nonipf
interstiti
lung
diseas
ild
scarc
describ
object
elucid
frequenc
viru
infect
patient
ipf
nonipf
ild
includ
idiopath
interstiti
pneumonia
iip
connect
tissu
diseas
ctd
associ
pneumonia
influenc
shortterm
mortal
method
prospect
enrol
adult
patient
acut
exacerb
ipf
nonipf
ild
admit
hospit
last
year
examin
respiratori
sampl
obtain
nasopharyng
sputum
bronchoalveolar
lavag
fluid
result
total
patient
identifi
consist
patient
acut
exacerb
ipf
patient
nonipf
ild
iip
n
ctdassoci
ip
n
patient
virus
detect
respiratori
sampl
includ
human
herpesviru
n
cytomegaloviru
cmv
plu
n
proport
viru
infect
ipf
nonipf
ild
group
compar
kaplanmei
surviv
curv
day
reveal
lower
surviv
probabl
viru
posit
group
n
viru
neg
group
n
p
howev
viru
infect
could
predict
surviv
probabl
use
simpl
logist
regress
analysi
conclus
viral
infect
mostli
cmv
identifi
patient
acut
exacerb
ipf
nonipf
ild
clinic
signific
shortterm
mortal
isol
respiratori
sampl
remain
determin
date
studi
address
etiolog
acut
exacerb
idiopath
pulmonari
fibrosi
ipf
impact
infect
yield
mix
result
furthermor
signific
viral
infect
type
interstiti
pneumonia
trigger
acut
exacerb
remain
determin
therefor
prospect
examin
relationship
viru
infect
acut
exacerb
interstiti
pneumonia
includ
ipf
type
idiopath
interstiti
pneumonia
iip
connect
tissu
diseas
ctd
associ
interstiti
pneumonia
prospect
enrol
adult
hospit
patient
acut
exacerb
interstiti
pneumonia
admit
kyorin
univers
hospit
august
august
definit
acut
exacerb
iip
base
previou
report
follow
http
receiv
novemb
receiv
revis
form
februari
accept
februari
unexplain
develop
dyspnea
within
day
presenc
new
bilater
pulmonari
ground
glass
abnorm
consolid
superimpos
background
reticular
andor
honeycomb
pattern
chest
comput
tomographi
acut
respiratori
symptom
pathogen
bacteri
bronchoalveolar
lavag
fluid
balf
exclus
altern
caus
left
heart
failur
pulmonari
embol
approv
patient
usual
interstiti
pneumonia
uip
pattern
radiolog
background
therefor
also
enrol
patient
acut
exacerb
ctdassoci
interstiti
pneumonia
regard
criteria
bronchoalveolar
lavag
procedur
consid
essenti
patient
enrol
studi
patient
previous
concurr
fulfil
consensu
criteria
american
thorac
societyeuropean
respiratori
societi
diagnosi
ipf
diagnos
acut
exacerb
ipf
respiratori
sampl
obtain
sputum
nasopharyng
swab
balf
within
first
h
admiss
hospit
clinic
data
obtain
day
admiss
diseas
sever
patient
evalu
gap
score
perform
time
prior
acut
exacerb
interstiti
lung
diseas
sampl
centrifug
g
min
viral
rna
dna
extract
supernat
use
qiaamp
viral
rna
mini
kit
qiagen
valencia
ca
usa
revers
transcript
rt
perform
use
rt
reagent
kit
takara
bio
otsu
japan
accord
manufactur
instruct
use
polymeras
chain
reaction
pcr
detect
variou
respiratori
virus
human
metapneumoviru
hmpv
human
rhinoviru
hrv
enteroviru
human
respiratori
syncyti
viru
hrsv
influenza
virus
b
c
human
parainfluenza
virus
hpiv
human
coronaviru
adenoviru
cytomegaloviru
cmv
human
herp
viru
hhv
human
parvoviru
varicella
zoster
viru
human
bocaviru
togeth
mycoplasma
pneumonia
chlamydophila
pneumonia
pcr
product
purifi
use
monofa
dna
purif
kit
gl
scienc
inc
shinjuku
tokyo
japan
sampl
collect
written
inform
consent
obtain
particip
legal
repres
studi
protocol
approv
ethic
committe
human
research
kyorin
univers
hospit
juli
protocol
carri
accord
approv
guidelin
statist
comparison
nonparametr
data
perform
use
mannwhitney
test
wilcoxon
signedrank
test
comparison
categor
data
perform
use
pearson
chisquar
test
test
twosid
valu
p
consid
statist
signific
data
analyz
use
spss
version
softwar
window
examin
total
patient
acut
exacerb
interstiti
pneumonia
studi
period
number
patient
ipf
nonipf
ild
fig
tabl
latter
group
consist
patient
iip
without
usual
interstiti
pneumonia
uip
pattern
patient
ctd
rheumatoid
arthriti
n
microscop
polyang
n
scleroderma
n
sjogren
syndrom
n
polymyos
n
dermatomyos
n
maletofemal
ratio
age
group
nonipf
ild
group
n
p
comorbid
two
group
compar
proport
copd
significantli
higher
ipf
group
nonipf
ild
group
vs
p
regard
thorac
highresolut
comput
tomographi
pattern
onequart
nonipf
ild
group
exhibit
uip
pattern
n
tabl
among
enrol
patient
respiratori
virus
n
cmv
plu
n
influenza
viru
n
hpiv
n
influenza
viru
plu
n
cmv
n
hmpv
n
hrv
n
tabl
two
case
methicillinsuscept
staphylococcu
aureu
hemophilu
influenza
sputum
sampl
could
consid
suffici
materi
evalu
furthermor
neither
mycoplasma
pneumonia
chlamydophila
pneumonia
isol
respiratori
sampl
proport
isol
respiratori
virus
compar
ipf
nonipf
ild
group
proport
respiratori
failur
ipf
nonipf
ild
group
similar
vs
admiss
tabl
howev
respiratori
rate
significantli
higher
ipf
group
median
breathsmin
iqr
nonipf
ild
group
median
breathsmin
iqr
p
tabl
addit
number
patient
home
oxygen
therapi
significantli
higher
ipf
group
nonipf
ild
group
vs
p
time
initi
onset
admiss
significantli
shorter
ipf
group
median
iqr
day
nonipf
ild
group
median
day
iqr
p
initi
treatment
group
differ
mortal
rate
day
day
day
compar
serum
laboratori
data
admiss
compar
ipf
nonipf
ild
group
valu
serum
marker
alveolar
injuri
significantli
higher
ipf
median
uml
iqr
nonipf
ild
group
median
uml
iqr
p
kaplanmei
surviv
curv
day
demonstr
viru
neg
group
n
exhibit
significantli
higher
surviv
probabl
viru
posit
group
n
p
logrank
test
fig
howev
viru
infect
could
predict
poor
surviv
probabl
simpl
logist
regress
analysi
two
group
similarli
focus
ipf
group
surviv
probabl
viru
neg
patient
n
posit
patient
n
significantli
differ
vs
p
fig
viru
infect
could
predict
poor
surviv
probabl
simpl
logist
regress
analysi
comparison
surviv
probabl
ipf
n
nonipf
ild
group
n
compar
p
fig
interestingli
surviv
probabl
significantli
lower
uip
group
n
nonuip
group
n
p
fig
howev
simpl
logist
regress
analysi
predict
poor
surviv
rate
patient
uip
pattern
addit
presenc
copd
home
oxygen
therapi
smoke
statu
could
predict
mortal
rate
among
enrol
patient
patient
perform
min
walk
test
data
pulmonari
function
test
avail
n
ipf
n
nonipf
n
ctd
associ
ip
perspect
diseas
sever
comparison
gap
score
ipf
nonipf
ild
show
ipf
significantli
higher
score
median
iqr
p
nonipf
ild
median
iqr
among
nonipf
ild
gap
score
nonuip
ctdassoci
diseas
compar
median
iqr
vs
median
iqr
p
comparison
ipf
ctdassoci
diseas
show
ipf
significantli
higher
score
ctd
associ
ip
p
analysi
demonstr
high
gap
score
predict
poor
surviv
probabl
simpl
logist
regress
analysi
present
studi
clearli
demonstr
respiratori
viru
infect
seen
patient
acut
exacerb
interstiti
pneumonia
proport
viru
isol
differ
ipf
nonipf
ild
group
addit
virusposit
patient
display
lower
surviv
probabl
assess
use
kaplanmei
test
viru
infect
could
predict
mortal
simpl
logist
regress
analysi
hand
result
rais
clinic
question
understand
role
viru
infect
acut
exacerb
interstiti
pneumonia
isol
respiratori
virus
consist
cmv
codetect
tang
et
al
report
stabl
patient
ipf
one
herp
virus
cmv
ebv
biopsi
specimen
might
contribut
chronic
irrit
antigen
stimul
inde
regardless
type
interstiti
pneumonia
account
n
total
isol
respiratori
virus
n
studi
rais
concern
whether
virus
truli
reflect
current
infect
hallmark
latent
infectionreactiv
hypothesi
latent
infect
reactiv
reinforc
result
demonstr
cmv
cytomegaloviru
hmpv
human
metapneumoviru
hpiv
human
parainfluenza
viru
hrv
human
rhinoviru
rsv
respiratori
syncyti
viru
elev
serum
atyp
lymphocyt
definit
evid
inclus
bodi
balf
absenc
cmv
antigenemia
due
clinic
cours
ushiki
et
al
report
case
ipf
japan
acut
exacerb
found
evid
rsv
one
case
cmv
two
case
brazil
santo
et
al
demonstr
ipf
acut
exacerb
case
exhibit
measl
cmv
infect
thu
role
viru
infect
ipf
nonipf
ild
case
remain
obscur
studi
higher
number
case
may
requir
futur
respiratori
virus
influenza
virus
hpiv
hrv
report
caus
lower
respiratori
symptom
andor
communityacquir
pneumonia
adult
recent
report
preval
viral
infect
adult
asthma
attack
patient
conduct
period
studi
frequenc
hrv
rsv
infect
seem
high
autumn
hmpv
like
occur
spring
influenza
viru
infect
common
tabl
comparison
clinic
find
ipf
nonipf
ild
case
winter
spring
howev
regard
acut
exacerb
interstiti
pneumonia
detect
pathogen
differ
asthma
attack
patient
seem
respiratori
sampl
whose
acut
exacerb
interstiti
pneumonia
influenc
respiratori
tract
viral
infect
present
studi
conduct
throughout
period
year
therebi
result
consid
repres
data
singl
tertiari
referr
center
japan
influenc
season
variat
evidenc
serum
data
admiss
procalcitonin
level
low
tabl
indic
exacerb
respiratori
statu
would
associ
viru
infect
bacteria
infect
consid
caus
acut
exacerb
interstiti
pneumonia
three
main
limit
studi
first
studi
lack
data
torqu
teno
viru
balf
previous
suggest
possibl
caus
acut
exacerb
ipf
second
pauciti
sampl
data
balf
anoth
limit
howev
present
studi
report
first
evid
viral
respiratori
infect
ipf
nonipf
ild
case
acut
exacerb
requir
hospit
admiss
accumul
case
may
requir
futur
studi
elucid
viru
detect
either
indic
latent
infect
andor
reactiv
respiratori
system
true
trigger
acut
exacerb
thirdli
regard
diseas
sever
patient
perform
gap
score
could
predict
mortal
singl
logist
regress
analysi
evalu
studi
conclus
suggest
viral
infect
mostli
cmv
detect
patient
ipf
nonipf
ild
acut
exacerb
clinic
signific
result
remain
determin
